• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

幽门螺杆菌谷氨酰胺-tRNA合成酶的晶体结构。

Crystal structure of glutamyl-tRNA synthetase from Helicobacter pylori.

作者信息

Davis Dylan E, Ayanlade Jesuferanmi P, Laseinde David T, Subramanian Sandhya, Udell Hannah, Lorimer Donald J, Dranow David M, Edwards Thomas E, Myler Peter J, Asojo Oluwatoyin A

机构信息

College of Arts and Science, Dartmouth College, Hanover, NH 03755, USA.

Dartmouth Cancer Center, One Medical Center Drive, Lebanon, NH 03756, USA.

出版信息

Acta Crystallogr F Struct Biol Commun. 2024 Dec 1;80(Pt 12):335-40. doi: 10.1107/S2053230X24011099.

DOI:10.1107/S2053230X24011099
PMID:39601417
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11614106/
Abstract

Helicobacter pylori is one of the most common bacterial infections; over two-thirds of the world's population is infected by early childhood. Persistent H. pylori infection results in gastric ulcers and cancers. Due to drug resistance, there is a need to develop alternative treatments to clear H. pylori. The Seattle Structural Genomics Center for Infectious Disease (SSGCID) conducts structure-function analysis of potential therapeutic targets from H. pylori. Glutamyl-tRNA synthetase (GluRS) is essential for tRNA aminoacylation and is under investigation as a bacterial drug target. The SSGCID produced, crystallized and determined the apo structure of H. pylori GluRS (HpGluRS). HpGluRS has the prototypical bacterial GluRS topology and has similar binding sites and tertiary structures to other bacterial GluRS that are promising drug targets. Residues involved in glutamate binding are well conserved in comparison with Pseudomonas aeruginosa GluRS (PaGluRS), which has been studied to develop promising new inhibitors for P. aeruginosa. These structural similarities can be exploited for drug discovery and repurposing to generate new antibacterials to clear persistent H. pylori infection and reduce gastric ulcers and cancer.

摘要

幽门螺杆菌是最常见的细菌感染之一;全球超过三分之二的人口在儿童早期就受到感染。幽门螺杆菌的持续感染会导致胃溃疡和癌症。由于耐药性的存在,需要开发替代疗法来清除幽门螺杆菌。西雅图传染病结构基因组学中心(SSGCID)对幽门螺杆菌潜在的治疗靶点进行结构-功能分析。谷氨酰胺-tRNA合成酶(GluRS)对于tRNA氨基酰化至关重要,目前正在作为一种细菌药物靶点进行研究。SSGCID制备、结晶并确定了幽门螺杆菌GluRS(HpGluRS)的无配体结构。HpGluRS具有典型的细菌GluRS拓扑结构,与其他有前景的细菌药物靶点GluRS具有相似的结合位点和三级结构。与铜绿假单胞菌GluRS(PaGluRS)相比,参与谷氨酸结合的残基高度保守,后者已被研究用于开发有前景的铜绿假单胞菌新抑制剂。这些结构上的相似性可用于药物发现和重新利用,以生成新的抗菌药物,清除幽门螺杆菌的持续感染,减少胃溃疡和癌症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f612/11614106/92c4425f814b/f-80-00335-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f612/11614106/17e320c265fb/f-80-00335-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f612/11614106/92c4425f814b/f-80-00335-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f612/11614106/17e320c265fb/f-80-00335-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f612/11614106/92c4425f814b/f-80-00335-fig2.jpg

相似文献

1
Crystal structure of glutamyl-tRNA synthetase from Helicobacter pylori.幽门螺杆菌谷氨酰胺-tRNA合成酶的晶体结构。
Acta Crystallogr F Struct Biol Commun. 2024 Dec 1;80(Pt 12):335-40. doi: 10.1107/S2053230X24011099.
2
Crystal structures of glutamyl-tRNA synthetase from Elizabethkingia anopheles and E. meningosepticum.嗜麦芽窄食单胞菌和脑膜炎败血伊丽莎白金菌的谷氨酰-tRNA 合成酶的晶体结构。
Acta Crystallogr F Struct Biol Commun. 2022 Aug 1;78(Pt 8):306-312. doi: 10.1107/S2053230X22007555. Epub 2022 Jul 28.
3
Identification of Chemical Compounds That Inhibit the Function of Glutamyl-tRNA Synthetase from Pseudomonas aeruginosa.抑制铜绿假单胞菌谷氨酰胺-tRNA合成酶功能的化合物鉴定
J Biomol Screen. 2015 Oct;20(9):1160-70. doi: 10.1177/1087057115591120. Epub 2015 Jun 26.
4
Structural characterization of glutamyl-tRNA synthetase (GluRS) from Plasmodium falciparum.恶性疟原虫谷氨酸-tRNA 合成酶(GluRS)的结构特征。
Mol Biochem Parasitol. 2023 Feb;253:111530. doi: 10.1016/j.molbiopara.2022.111530. Epub 2022 Nov 9.
5
Structural basis for substrate and antibiotic recognition by Helicobacter pylori isoleucyl-tRNA synthetase.幽门螺杆菌异亮氨酰-tRNA 合成酶识别底物和抗生素的结构基础。
FEBS Lett. 2024 Mar;598(5):521-536. doi: 10.1002/1873-3468.14805. Epub 2024 Jan 21.
6
Co-crystal structure of Helicobacter pylori biotin protein ligase with biotinyl-5-ATP.幽门螺杆菌生物素蛋白连接酶与生物素-5-ATP的共晶体结构
Acta Crystallogr F Struct Biol Commun. 2025 Jan 1;81(Pt 1):11-18. doi: 10.1107/S2053230X24012056.
7
Crystal structure of glutamyl-queuosine tRNAAsp synthetase complexed with L-glutamate: structural elements mediating tRNA-independent activation of glutamate and glutamylation of tRNAAsp anticodon.与L-谷氨酸复合的谷氨酰胺-反密码子天冬氨酸tRNA合成酶的晶体结构:介导谷氨酸非tRNA依赖性激活及天冬氨酸tRNA反密码子谷氨酰化的结构元件
J Mol Biol. 2008 Sep 19;381(5):1224-37. doi: 10.1016/j.jmb.2008.06.053. Epub 2008 Jun 26.
8
tRNAGlu increases the affinity of glutamyl-tRNA synthetase for its inhibitor glutamyl-sulfamoyl-adenosine, an analogue of the aminoacylation reaction intermediate glutamyl-AMP: mechanistic and evolutionary implications.tRNAGlu增加了谷氨酰胺-tRNA合成酶对其抑制剂谷氨酰胺-氨磺酰腺苷(一种氨酰化反应中间体谷氨酰胺-AMP的类似物)的亲和力:对机制和进化的启示。
PLoS One. 2015 Apr 10;10(4):e0121043. doi: 10.1371/journal.pone.0121043. eCollection 2015.
9
Recognition of tRNAGln by Helicobacter pylori GluRS2--a tRNAGln-specific glutamyl-tRNA synthetase.幽门螺杆菌谷氨酰胺特异性谷氨酰-tRNA合成酶2对谷氨酰胺tRNA的识别
Nucleic Acids Res. 2009 Nov;37(20):6942-9. doi: 10.1093/nar/gkp754. Epub 2009 Sep 15.
10
Dispensability of zinc and the putative zinc-binding domain in bacterial glutamyl-tRNA synthetase.细菌谷氨酰胺-tRNA合成酶中锌的可缺失性及假定的锌结合结构域
Biosci Rep. 2015 Mar 31;35(2):e00184. doi: 10.1042/BSR20150005.

引用本文的文献

1
Using resources generated by the Seattle Structural Genomics Center for Infectious Disease (SSGCID) for training early career researchers.利用西雅图传染病结构基因组学中心(SSGCID)生成的资源来培训早期职业研究人员。
Acta Crystallogr F Struct Biol Commun. 2025 Jun 1;81(Pt 6):222-225. doi: 10.1107/S2053230X25003930. Epub 2025 May 6.
2
Architecture of glutamyl-tRNA synthetase defines a subfamily of dimeric class Ib aminoacyl-tRNA synthetases.谷氨酰胺-tRNA合成酶的结构定义了二聚体Ib类氨酰-tRNA合成酶的一个亚家族。
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2504757122. doi: 10.1073/pnas.2504757122. Epub 2025 May 9.

本文引用的文献

1
Inhibition and structural insights of leishmanial glutamyl-tRNA synthetase for designing potent therapeutics.抑制利什曼原虫谷氨酰-tRNA 合成酶及其结构见解用于设计有效的治疗药物。
Int J Biol Macromol. 2024 Jan;254(Pt 2):127756. doi: 10.1016/j.ijbiomac.2023.127756. Epub 2023 Oct 29.
2
Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts.鉴定有效的和选择性的恶性疟原虫肝脏期休眠子和裂殖体的 N-豆蔻酰转移酶抑制剂。
Nat Commun. 2023 Sep 5;14(1):5408. doi: 10.1038/s41467-023-41119-7.
3
Evolution of Resistance to Antibiotics: A Topic of Increasing Concern.
抗生素耐药性的演变:一个日益受到关注的话题。
Antibiotics (Basel). 2023 Feb 4;12(2):332. doi: 10.3390/antibiotics12020332.
4
Crystal structures of glutamyl-tRNA synthetase from Elizabethkingia anopheles and E. meningosepticum.嗜麦芽窄食单胞菌和脑膜炎败血伊丽莎白金菌的谷氨酰-tRNA 合成酶的晶体结构。
Acta Crystallogr F Struct Biol Commun. 2022 Aug 1;78(Pt 8):306-312. doi: 10.1107/S2053230X22007555. Epub 2022 Jul 28.
5
Aminoacyl-tRNA Synthetases as Valuable Targets for Antimicrobial Drug Discovery.氨酰-tRNA 合成酶作为抗菌药物发现的有价值靶点。
Int J Mol Sci. 2021 Feb 10;22(4):1750. doi: 10.3390/ijms22041750.
6
Glutaminyl-tRNA Synthetase from Pseudomonas aeruginosa: Characterization, structure, and development as a screening platform.铜绿假单胞菌谷氨酰-tRNA 合成酶:特性、结构及作为筛选平台的发展。
Protein Sci. 2020 Apr;29(4):905-918. doi: 10.1002/pro.3800. Epub 2019 Dec 24.
7
Development of treatment: How do we manage antimicrobial resistance?治疗方法的发展:我们如何应对抗菌药物耐药性?
World J Gastroenterol. 2019 Apr 28;25(16):1907-1912. doi: 10.3748/wjg.v25.i16.1907.
8
Aminoacyl-tRNA synthetases as therapeutic targets.氨酰-tRNA 合成酶作为治疗靶点。
Nat Rev Drug Discov. 2019 Aug;18(8):629-650. doi: 10.1038/s41573-019-0026-3.
9
Infection.感染
N Engl J Med. 2019 Mar 21;380(12):1158-1165. doi: 10.1056/NEJMcp1710945.
10
Automatic recognition of ligands in electron density by machine learning.利用机器学习自动识别电子密度中的配体。
Bioinformatics. 2019 Feb 1;35(3):452-461. doi: 10.1093/bioinformatics/bty626.